ARTICLE | Distillery Therapeutics
Inflammation; infectious disease
February 13, 2018 4:49 PM UTC
In vitro and mouse studies suggest inhibiting the MAC-1-CD40L interaction could help treat systemic inflammatory response syndrome (SIRS) and sepsis. In a mouse cell-based assay, a mAb against the M7 ...
BCIQ Company Profiles